Abstract
There are some reports which show that omega-3 fatty acids extracted from either animals or plants can be used to reduce glucose levels in diabetic patients; however, the results are very confusing; perhaps this phenomenon is due to the different protocols used. Analyzing these data, this study aimed to evaluate the biological activity of the oil extracted from Crocodylus moreletii at a dose of 100, 200, and 300 µl/kg using metformin glibenclamide and sodium oleate as controls in a diabetic rat model. The results showed that oil Crocodylus moreletii lowered glucose levels in a dose-dependent manner than untreated diabetic rats. Furthermore, the effects produced by Crocodylus moreletii oil and sodium oleate on glucose concentration were very similar. However, the biological activity exerted by glibenclamide and metformin on glucose levels was different from to effect induced by Crocodylus moreletii oil and sodium oleate. In conclusion, the biological activity of Crocodylus moreletii oil is interesting and could be considered a therapeutic alternative for the treatment of diabetes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
